According to the 2024 Chinese Guidelines for Diabetes Prevention and Treatment, the normal FBG reference range for healthy individuals in a fasting state is 3.9 to 6.1 mmol/L. An FBG level ...

The trials are part of Lilly’s Phase III ACHIEVE clinical development program, which has enrolled more than 6,000 people with type 2 diabetes across five global registrational trials.